SEC Form 4 · accession 0001209191-18-040072
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jun 22, 2018
Accepted (ET)
Jun 29, 2018 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 22, 2018 | S | 747,942 | $1.00 | D | 0 | D | |
| Common StockF2 | holding | — | — | — | 1,463,839 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are held by Amerop Holdings, Inc., a Colorado corporation ("Amerop"). Leonard P. Wessell III is the sole stockholder of Amerop and may be deemed an indirect beneficial owner of securities held by Amerop.
- F2Shares held by Series A of White Winston Select Asset Fund Series Fund MP-18, LLC, a series of a limited liability company organized under the laws of the state of Delaware in which Amerop holds membership interests and certain approval rights over the disposition of Issuer shares. The reporting persons disclaim beneficial ownership of such shares, except to the extent of their pecuniary interest therein.